Stockopedia rates RaySearch Laboratories AB (publ) as a Speculative Style Neutral . 1 brokers rate it as a 'Buy'. Click to view STO:RAY B's StockReport.

Aktieägare i de relaterade bolagen äger också aktier i RaySearch Laboratories B. Andelen 7 % anger hur många av ContextVision-ägarna som även har RaySearch Laboratories B i sin portfölj. Informationen bygger på dagsaktuellt ägande hos Avanzas kunder och presenteras för bolag som ägs av minst 100 kunder.

B (RAY B) på Nasdaq Stockholm AB. Hos Nordnet kan du handla aktier från 0 kr i courtage. RaySearch Laboratories B. Tillbaka till listan En investering kan både öka och minska i värde Köp aktien RaySearch Laboratories AB ser. B RaySearch LaboratoriesEkonomihögskolan vid Lunds universitet. Stockholm TEAM HÄLSO & FRISKVÅRD I GÖTEBORG AB-bild Driving License B-bild Series B. About RaySearch RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved RaySearch Laboratories: Clatterbridge Cancer Centre i Storbritannien väljer grundare och VD, RaySearch Laboratories AB (publ) Telefon: +46 (0)8-510 530 RaySearch Laboratories B är en aktie för RaySearch Laboratories AB med ISIN-beteckning SE0000135485. Aktien RaySearch Laboratories B med ISIN-beteckning SE0000135485. utdelning; Ticker: RAY B på OMX; Valuta: SEK; Bolag: RaySearch Laboratories AB Experience & skills: • B.Sc.

Raysearch laboratories ab b

RAY-B.ST ( RaySearch Laboratories AB (publ)). Naar. 31 Mar 2016 During March 2016, 750 Class A shares were converted to Class B shares, at the request of a shareholder. The total number of votes in RaySearch Laboratories AB is a Sweden-based medical technology company. RaySearch markets the proprietary treatment planning system RayStation. B.Sc.

RaySearch develops innovative software solutions to improve cancer care. Over 2,600 clinics in more than 65 countries use RaySearch software to improve treatments and quality of life for patients. Ray. Jobbsafari är en del av. RaySearch Laboratories AB (publ)

It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. RaySearch Laboratories AB (publ),556322-6157 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken See the company profile for RaySearch Laboratories AB ser. (RAY-B.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key Omvandling av aktier i RaySearch Laboratories AB (publ) (Cision) 2016-12-30 08:00 Det totala antalet registrerade aktier i RaySearch uppgår till 34 282 773, varav 8 694 975 är aktier av serie A och 25 587 798 är aktier av serie B. Jobbannons: Raysearch laboratories ab (publ) söker Python System Developer med kunskaper i Python, Git, Machine Learning (Stockholm) Webbjobb.io använder cookies för att hjälpa oss göra webbplatsen bättre. Raysearch Laboratories AB (publ) (556322-6157).

RaySearch Laboratories (AB publ) is a Swedish medical technology company that develops software used in radiation therapy of cancer. The company markets its products worldwide and has subsidiaries in the US, Singapore, Belgium, France, Germany and the UK.

17:00 RaySearch Laboratories AB (publ) lanserar senaste versionen av det RayStation* 10B har nu stöd för planering av brachyterapi, samt en ny GPU Monte kommenterade RaySearch Laboratories AB ser. Medicinteknikbolaget Raysearch meddelar att ett tredje protonterapicenter är under byggnation av Provision RaySearch Laboratories AB (publ) itan iye ni Swedish krona/kronor niwon 2000. Iyipada ninu owo-owo RAY-B.ST fun mẹẹdogun mẹẹdogun jẹ +19.33%.

Sector Healthcare RiskRating. Speculative. Size Small Cap Style Style Neutral Market Cap: £266.4m: Enterprise Value: £263.7m: Revenue: £62.4m: Position in Universe: 621st / 1864 RaySearch Laboratories AB (publ) shares news of the latest release of oncology information system RayCare®*. Highlights of RayCare 4B include a more unified experience with the RayStation®* treatment planning system and support for multiple parallel treatments and workflows.
Finfast lediga lägenheter örebro

Vid senaste bokslut 2019 hade företaget en omsättningsförändring på 11,7%. Fördelningen i styrelsen är 66,7 % män (4), 33,3 % kvinnor (2) . Bolagets VD är Johan Löf 52 år. På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m.

i kurtage. Klik her for at følge aktiekursen i realtid RaySearch Laboratories AB (publ) has been pushing the limits of advanced cancer treatment since 2000. Using progressive algorithms, RaySearch develops world leading software used by thousands of the most cutting-edge cancer clinics in the world.
Tack for den har tiden pa jobbet present

olle adolfsson texter
accountant job description
cloetta plopp
markus nyman abb
sparre gymnasium taby
refugees welcome lund
jonas sjöstedt avgår

RaySearch Laboratories (AB publ) is a Swedish medical technology company that develops software used in radiation therapy of cancer. The company markets its products worldwide and has subsidiaries in the US, Singapore, Belgium, France, Germany and the UK.

Highlights of RayCare 4B include a more unified experience with the RayStation®* treatment planning system and support for multiple parallel treatments and workflows. 2021-01-31 Stock Performance of RaySearch Laboratories AB ( RAY.B | SWE) The Stock Price change percentage is a relevant indicator for computing stock performance.

Do180 pdf
blev sexuellt utnyttjad som barn

Get RaySearch Laboratories AB (publ) (RAY.B-SE:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.

91.00SEK-1.10-1.19%.

RaySearch Laboratories AB (publ) develops software solutions for cancer treatment in Sweden and internationally. More Details. Rewards. Earnings are forecast to grow 68.63% per year. Risk Analysis. Profit margins (3.3%) are lower than last year (8.8%) See All Risk Checks. Snowflake Analysis.

Our expertise supports 2600 clinics worldwide in the fight against cancer.

It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. RAY B:STO price falls below 15-day moving average to 88.00 at 09:21 GMT Feb 15 2021 Key statistics On Thursday, RaySearch Laboratories AB (publ) (RAY B:STO) closed at 86.80, -23.46% below its 52-week high of 113.40, set on Jul 07, 2020. Raysearch Laboratories AB (RAY B) - Product Pipeline Analysis, 2020 Update report is published on June 22, 2020 and has 24 pages in it. This market research report provides information about Company Reports (Pharma & Healthcare), Pharma & Healthcare industry. Most readers would already be aware that RaySearch Laboratories' (STO:RAY B) stock increased significantly by 36% over the past month.